Clinical Trial Update: A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating low-dose intracoronary thrombolytic therapy in ST-elevation myocardial infarction patients with elevated IMR (>32). Recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Intracoronary thrombolytic therapy (low-dose)

Snippet

Sponsor: University of Sydney | Conditions: STEMI, Elevated IMR (>32) | Phase 3 | Status: RECRUITING